Global Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Regional Outlook and Forecast, 2023 - 2030

Global Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Regional Outlook and Forecast, 2023 - 2030


The Global Iliac Stent Market size is expected to reach $1.4 billion by 2030, rising at a market growth of 5.9% CAGR during the forecast period.

North America has a significant prevalence of PAD. Therefore, the North America region captured $400.0 million revenue in the market in 2022. The incidence of PAD is predicted to climb with age and the prevalence of risk factors like diabetes and obesity rising, which will fuel the need for iliac stents as the main treatment option for revascularization and symptom relief.

PAD is a common circulatory problem in which narrowed arteries reduce blood flow to the limbs, most commonly affecting the lower extremities. It affects a large population worldwide, particularly among older adults and individuals with risk factors such as smoking, diabetes, hypertension, and dyslipidemia. Hence, the prevalence of peripheral artery disease is propelling the market’s growth.

Aging is one of the major risk factors for vascular diseases such as PAD, which commonly affects the iliac arteries. As individuals age, the walls of their blood vessels may become thicker and less elastic, leading to plaque buildup and arteries narrowing. Therefore, the increasing aging population is driving the growth of the market.

However, the cost of iliac stent placement includes various components, such as the price of the stent device, hospital fees, physician fees, anesthesia costs, imaging studies, medications, and follow-up care. These expenses can add to a substantial financial burden for patients and healthcare systems, particularly in cases where multiple stents are required, or complications arise during the procedure. Thus, the high cost of treatment is hampering the market’s growth.

During the height of the pandemic, many elective medical procedures, including those related to peripheral artery disease (PAD) and iliac stenting, were postponed or canceled to conserve healthcare resources and reduce the risk of viral transmission. This temporarily decreased procedural volumes and revenue for manufacturers and healthcare providers in the market. Thus, the COVID-19 pandemic had a negative impact on the market.

By Artery Lesions Analysis

On the basis of artery lesions, the market is segmented into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. The common iliac artery lesions segment recorded 60.6% revenue share in the market in 2022. Common iliac artery lesions have significant clinical implications, as they can compromise blood flow to both the internal and external iliac arteries, affecting perfusion to the pelvis, lower extremities, and vital organs.

By End-use Analysis

Based on end-use, the market is categorized into hospitals, outpatient facilities, and others. The outpatient facilities segment witnessed 26.7% revenue share in the market in 2022. Outpatient facilities offer a more comfortable and convenient environment for patients undergoing vascular interventions like iliac stent placement.

By Type Analysis

Based on type, the market is divided into self-expandable stents, balloon-expandable stents, and others. In 2022, the self-expandable stents segment garnered 62.3% revenue share in the market. Self-expandable stents are designed to be flexible and conformable, allowing for precise deployment and adaptation to the shape and curvature of the iliac arteries.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated 22.6% revenue share in the market in 2022. Urbanization and lifestyle changes in the Asia Pacific region have led to the adoption of Westernized lifestyles characterized by physical inactivity, unhealthy dietary habits, and increased prevalence of risk factors for cardiovascular diseases.

List of Key Companies Profiled
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Boston Scientific Corporation
  • W. L. Gore & Associates, Inc.
  • Medtronic PLC
  • Cook Medical, Inc.(Cook Group)
  • Terumo Corporation
  • iVascular S.L.U.
  • Getinge AB
  • Biotronik SE & Co. KG
Global Iliac Stent Market Report Segmentation

By Artery Lesions
  • Common Iliac Artery Lesions
  • Severe Calcified Lesions
  • Complete Obstructive Lesions
By End-use
  • Hospitals
  • Outpatient Facilities
  • Others
By Type
  • Self-expandable Stents
  • Balloon-expandable Stents
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Iliac Stent Market, by Artery Lesions
1.4.2 Global Iliac Stent Market, by End-use
1.4.3 Global Iliac Stent Market, by Type
1.4.4 Global Iliac Stent Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Global Iliac Stent Market by Artery Lesions
4.1 Global Common Iliac Artery Lesions Market by Region
4.2 Global Severe Calcified Lesions Market by Region
4.3 Global Complete Obstructive Lesions Market by Region
Chapter 5. Global Iliac Stent Market by End-use
5.1 Global Hospitals Market by Region
5.2 Global Outpatient Facilities Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Iliac Stent Market by Type
6.1 Global Self-expandable Stents Market by Region
6.2 Global Balloon-expandable Stents Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Iliac Stent Market by Region
7.1 North America Iliac Stent Market
7.1.1 North America Iliac Stent Market by Artery Lesions
7.1.1.1 North America Common Iliac Artery Lesions Market by Country
7.1.1.2 North America Severe Calcified Lesions Market by Country
7.1.1.3 North America Complete Obstructive Lesions Market by Country
7.1.2 North America Iliac Stent Market by End-use
7.1.2.1 North America Hospitals Market by Country
7.1.2.2 North America Outpatient Facilities Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America Iliac Stent Market by Type
7.1.3.1 North America Self-expandable Stents Market by Country
7.1.3.2 North America Balloon-expandable Stents Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Iliac Stent Market by Country
7.1.4.1 US Iliac Stent Market
7.1.4.1.1 US Iliac Stent Market by Artery Lesions
7.1.4.1.2 US Iliac Stent Market by End-use
7.1.4.1.3 US Iliac Stent Market by Type
7.1.4.2 Canada Iliac Stent Market
7.1.4.2.1 Canada Iliac Stent Market by Artery Lesions
7.1.4.2.2 Canada Iliac Stent Market by End-use
7.1.4.2.3 Canada Iliac Stent Market by Type
7.1.4.3 Mexico Iliac Stent Market
7.1.4.3.1 Mexico Iliac Stent Market by Artery Lesions
7.1.4.3.2 Mexico Iliac Stent Market by End-use
7.1.4.3.3 Mexico Iliac Stent Market by Type
7.1.4.4 Rest of North America Iliac Stent Market
7.1.4.4.1 Rest of North America Iliac Stent Market by Artery Lesions
7.1.4.4.2 Rest of North America Iliac Stent Market by End-use
7.1.4.4.3 Rest of North America Iliac Stent Market by Type
7.2 Europe Iliac Stent Market
7.2.1 Europe Iliac Stent Market by Artery Lesions
7.2.1.1 Europe Common Iliac Artery Lesions Market by Country
7.2.1.2 Europe Severe Calcified Lesions Market by Country
7.2.1.3 Europe Complete Obstructive Lesions Market by Country
7.2.2 Europe Iliac Stent Market by End-use
7.2.2.1 Europe Hospitals Market by Country
7.2.2.2 Europe Outpatient Facilities Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe Iliac Stent Market by Type
7.2.3.1 Europe Self-expandable Stents Market by Country
7.2.3.2 Europe Balloon-expandable Stents Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Iliac Stent Market by Country
7.2.4.1 Germany Iliac Stent Market
7.2.4.1.1 Germany Iliac Stent Market by Artery Lesions
7.2.4.1.2 Germany Iliac Stent Market by End-use
7.2.4.1.3 Germany Iliac Stent Market by Type
7.2.4.2 UK Iliac Stent Market
7.2.4.2.1 UK Iliac Stent Market by Artery Lesions
7.2.4.2.2 UK Iliac Stent Market by End-use
7.2.4.2.3 UK Iliac Stent Market by Type
7.2.4.3 France Iliac Stent Market
7.2.4.3.1 France Iliac Stent Market by Artery Lesions
7.2.4.3.2 France Iliac Stent Market by End-use
7.2.4.3.3 France Iliac Stent Market by Type
7.2.4.4 Russia Iliac Stent Market
7.2.4.4.1 Russia Iliac Stent Market by Artery Lesions
7.2.4.4.2 Russia Iliac Stent Market by End-use
7.2.4.4.3 Russia Iliac Stent Market by Type
7.2.4.5 Spain Iliac Stent Market
7.2.4.5.1 Spain Iliac Stent Market by Artery Lesions
7.2.4.5.2 Spain Iliac Stent Market by End-use
7.2.4.5.3 Spain Iliac Stent Market by Type
7.2.4.6 Italy Iliac Stent Market
7.2.4.6.1 Italy Iliac Stent Market by Artery Lesions
7.2.4.6.2 Italy Iliac Stent Market by End-use
7.2.4.6.3 Italy Iliac Stent Market by Type
7.2.4.7 Rest of Europe Iliac Stent Market
7.2.4.7.1 Rest of Europe Iliac Stent Market by Artery Lesions
7.2.4.7.2 Rest of Europe Iliac Stent Market by End-use
7.2.4.7.3 Rest of Europe Iliac Stent Market by Type
7.3 Asia Pacific Iliac Stent Market
7.3.1 Asia Pacific Iliac Stent Market by Artery Lesions
7.3.1.1 Asia Pacific Common Iliac Artery Lesions Market by Country
7.3.1.2 Asia Pacific Severe Calcified Lesions Market by Country
7.3.1.3 Asia Pacific Complete Obstructive Lesions Market by Country
7.3.2 Asia Pacific Iliac Stent Market by End-use
7.3.2.1 Asia Pacific Hospitals Market by Country
7.3.2.2 Asia Pacific Outpatient Facilities Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Iliac Stent Market by Type
7.3.3.1 Asia Pacific Self-expandable Stents Market by Country
7.3.3.2 Asia Pacific Balloon-expandable Stents Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Iliac Stent Market by Country
7.3.4.1 China Iliac Stent Market
7.3.4.1.1 China Iliac Stent Market by Artery Lesions
7.3.4.1.2 China Iliac Stent Market by End-use
7.3.4.1.3 China Iliac Stent Market by Type
7.3.4.2 Japan Iliac Stent Market
7.3.4.2.1 Japan Iliac Stent Market by Artery Lesions
7.3.4.2.2 Japan Iliac Stent Market by End-use
7.3.4.2.3 Japan Iliac Stent Market by Type
7.3.4.3 India Iliac Stent Market
7.3.4.3.1 India Iliac Stent Market by Artery Lesions
7.3.4.3.2 India Iliac Stent Market by End-use
7.3.4.3.3 India Iliac Stent Market by Type
7.3.4.4 South Korea Iliac Stent Market
7.3.4.4.1 South Korea Iliac Stent Market by Artery Lesions
7.3.4.4.2 South Korea Iliac Stent Market by End-use
7.3.4.4.3 South Korea Iliac Stent Market by Type
7.3.4.5 Singapore Iliac Stent Market
7.3.4.5.1 Singapore Iliac Stent Market by Artery Lesions
7.3.4.5.2 Singapore Iliac Stent Market by End-use
7.3.4.5.3 Singapore Iliac Stent Market by Type
7.3.4.6 Malaysia Iliac Stent Market
7.3.4.6.1 Malaysia Iliac Stent Market by Artery Lesions
7.3.4.6.2 Malaysia Iliac Stent Market by End-use
7.3.4.6.3 Malaysia Iliac Stent Market by Type
7.3.4.7 Rest of Asia Pacific Iliac Stent Market
7.3.4.7.1 Rest of Asia Pacific Iliac Stent Market by Artery Lesions
7.3.4.7.2 Rest of Asia Pacific Iliac Stent Market by End-use
7.3.4.7.3 Rest of Asia Pacific Iliac Stent Market by Type
7.4 LAMEA Iliac Stent Market
7.4.1 LAMEA Iliac Stent Market by Artery Lesions
7.4.1.1 LAMEA Common Iliac Artery Lesions Market by Country
7.4.1.2 LAMEA Severe Calcified Lesions Market by Country
7.4.1.3 LAMEA Complete Obstructive Lesions Market by Country
7.4.2 LAMEA Iliac Stent Market by End-use
7.4.2.1 LAMEA Hospitals Market by Country
7.4.2.2 LAMEA Outpatient Facilities Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA Iliac Stent Market by Type
7.4.3.1 LAMEA Self-expandable Stents Market by Country
7.4.3.2 LAMEA Balloon-expandable Stents Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Iliac Stent Market by Country
7.4.4.1 Brazil Iliac Stent Market
7.4.4.1.1 Brazil Iliac Stent Market by Artery Lesions
7.4.4.1.2 Brazil Iliac Stent Market by End-use
7.4.4.1.3 Brazil Iliac Stent Market by Type
7.4.4.2 Argentina Iliac Stent Market
7.4.4.2.1 Argentina Iliac Stent Market by Artery Lesions
7.4.4.2.2 Argentina Iliac Stent Market by End-use
7.4.4.2.3 Argentina Iliac Stent Market by Type
7.4.4.3 UAE Iliac Stent Market
7.4.4.3.1 UAE Iliac Stent Market by Artery Lesions
7.4.4.3.2 UAE Iliac Stent Market by End-use
7.4.4.3.3 UAE Iliac Stent Market by Type
7.4.4.4 Saudi Arabia Iliac Stent Market
7.4.4.4.1 Saudi Arabia Iliac Stent Market by Artery Lesions
7.4.4.4.2 Saudi Arabia Iliac Stent Market by End-use
7.4.4.4.3 Saudi Arabia Iliac Stent Market by Type
7.4.4.5 South Africa Iliac Stent Market
7.4.4.5.1 South Africa Iliac Stent Market by Artery Lesions
7.4.4.5.2 South Africa Iliac Stent Market by End-use
7.4.4.5.3 South Africa Iliac Stent Market by Type
7.4.4.6 Nigeria Iliac Stent Market
7.4.4.6.1 Nigeria Iliac Stent Market by Artery Lesions
7.4.4.6.2 Nigeria Iliac Stent Market by End-use
7.4.4.6.3 Nigeria Iliac Stent Market by Type
7.4.4.7 Rest of LAMEA Iliac Stent Market
7.4.4.7.1 Rest of LAMEA Iliac Stent Market by Artery Lesions
7.4.4.7.2 Rest of LAMEA Iliac Stent Market by End-use
7.4.4.7.3 Rest of LAMEA Iliac Stent Market by Type
Chapter 8. Company Profiles
8.1 Becton, Dickinson, and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Trials and Approvals:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 W. L. Gore & Associates, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Trials and Approvals:
8.5.6 SWOT Analysis
8.6 Cook Medical, Inc. (Cook Group)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Trials and Approvals:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 iVascular S.L.U.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Getinge AB
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials and Approvals:
8.9.6 SWOT Analysis
8.10. Biotronik SE & Co. KG
8.10.1 Company Overview
8.10.2 SWOT Analysis
Chapter 9. Winning Imperatives of Iliac Stent Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings